KrioRus Competitors

We are spearheading the next agricultural revolution: Cellular Agriculture. Cellular agriculture allows us to make milk, eggs, meat, leather, fur, rhino horn, and any other animal products from cell cultures rather than from animals. Cellular agriculture is a groundbreaking field that is still not adequately supported by established funding channels. This is where New Harvest comes in: 1) We coordinate and catalyze funding into open cellular agriculture research, engaging external funding and partnerships as much as possible to grow the pool of people and institutions truly invested. Every piece of research we fund strategically contributes to building the field, so that the whole of research we fund is greater than the sum of its parts. Like all pioneering scientific organizations, we fund neglected work. 2) We convene the community that is building this field (scientists, academia, funders, industry, policy-makers, regulatory authorities, etc.), fostering collaboration and a divide-and-conquer attitude. 3) We inform stakeholders and the public at large (from mass media to teaching cellular agriculture in universities) to draw more funds, talent, and acceptance to the field. We are planting the seeds of a new bioeconomy by supporting pioneers in the emerging field of cellular agriculture.

In 1972, Alcor was incorporated as the Alcor Society for Solid State Hypothermia in the State of California by Fred and Linda Chamberlain. (The name was changed to Alcor Life Extension Foundation in 1977.) The nonprofit organization was conceived as a rational, technology-oriented cryonics organization that would be managed on a fiscally conservative basis by a self perpetuating Board. Alcor advertised in direct mailings and offered seminars in order to attract members and bring attention to the cryonics movement. On July 16, 1976, Alcor performed its first human cryopreservation. At this time, Alcor’s office consisted of a mobile surgical unit in a large van. Trans Time, Inc., a cryonics organization in the San Francisco Bay Area, provided long-term patient storage until Alcor began doing its own storage in 1982. By 1990 Alcor had grown to 300 members. In response to concerns that the California facility was too small and vulnerable to earthquake risk, the organization purchased a building in Scottsdale, Arizona in 1993 and moved its patients to it in 1994. In 1997, after a substantial effort led by then-president Steve Bridge, Alcor formed the Patient Care Trust as an entirely separate entity to manage and protect the funding for cryopatients. Alcor remains the only cryonics organization to segregate and protect patient funding in this way. Alcor currently has around 1,000 members and 117 patients.

Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.